- Pharmacists - Required Notification and Authorized Substitution - Lower-Costing Drugs, Medical Devices, and Biological Products
- Sponsored by
- Chair, Health and Government Operations Committee (By Request - Departmental - Health)
- In the House - Hearing 2/25 at 1:00 p.m.
- Fiscal and Policy Note
Requiring a pharmacist or a pharmacist's designee who is under certain supervision to inform a certain consumer of the availability of certain therapeutically equivalent drugs, substantially equivalent medical devices, or interchangeable biological products and the cost difference between those drugs, devices, or products and certain prescribed drugs, medical devices, or biological products; etc.
Bill File Type: Regular
Effective Date(s): January 1, 2021
By Request of the Governor
Last Updated: 2/26/2020 10:52 AM